{
    "code": "10000841",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000841",
    "time": "2022-05-27 04:56:58",
    "許可證字號": "衛署菌疫輸字第000841號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/07\/12",
    "發證\/登錄日期": "96\/07\/12",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA01000084106",
    "中文品名": "“國血製劑益康”人類免疫球蛋白靜脈注射劑",
    "英文品名": "&quot;TBSF&quot; Human Immunoglobulin for Intravenous Use",
    "適應症": "IgG的替代治療用藥，適應症包括：1.原發性免疫不全症（primary immune deficiency）。2.由潛在疾病或治療所引發之次發性症狀性低伽瑪球蛋白血症。\r\n用於改善免疫調節機能，適應症包括：3.原發性血小板缺乏性紫斑症【idiopathic thrombocytopenic purpura（ITP）】，高危險出血的成人或小孩ITP患者；或者，手術前用以修正血小板數目。4.異體骨髓移植（allogeneic bone marrow transplantation）。5.川崎氏症（Kawasaki Disease）。6. Guillain-Barré 症候群(Guillain-Barré Syndrome (GBS))。",
    "劑型": "270注射劑",
    "包裝": "50ml或200ml瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "血液衍生產品",
    "監視期限": "",
    "主成分略述": "Human Immunoglobulin G",
    "限制項目": "02輸　入",
    "申請商名稱": "1014901100  醫療財團法人台灣血液基金會",
    "申請商地址": "台北市中正區南海路３號３樓",
    "主製造廠": [
        {
            "": "AUSTRALIA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "8004000650",
            "成分名稱": "Human Immunoglobulin G",
            "含量描述": "",
            "含量": "60.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "附件二_印妥仿單電子檔020008410001-110-06-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000841&Seq=008&Type=9"
        },
        {
            "title": "Cartons _IVIG-105-06-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000841&Seq=002&Type=8"
        }
    ]
}